Fig. 3

The cumulative rate of treat-to-target within the first year between 3 clusters. Patients in Cluster 2 were more likely to achieve treat-to-target status compared to those in Cluster 1 and 3 (P < 0.001). Association between 3 clusters and treat-to-target after adjusted for therapy of PAH and CTD (P < 0.001)